This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Departures of key staff from the FDA could lead to delays in inspections and pro...
The agency noted that quantity restrictions can alter the competitive dynamics o...
MONDAY, March 17, 2025 -- Geospatial clusters are seen in pediatric firearm inj...
MONDAY, March 17, 2025 -- The global burden of diabetic nephropathy increased f...
Under one of two policy tools that the U.K. uses to control drug costs, the Brit...
The FDA chief counsel pick quickly attracted controversy due to her prior defens...
David Pacitti is leaving the imaging giant to become CEO of Avanos Medical, afte...
MONDAY, March 17, 2025 -- Higher menopausal symptom burden is associated with p...
MONDAY, March 17, 2025 -- From 2015 to 2023, there was an increase in the numbe...
MONDAY, March 17, 2025 -- People who take over-the-counter (OTC) pain relievers...
MONDAY, March 17, 2025 -- In 2023, reported breast and colorectal cancer screen...
MONDAY, March 17, 2025 -- For children with mild sleep disordered breathing (SD...
MONDAY, March 17, 2025 -- For patients with distant-stage cancers, there was an...
Apriori Bio has become the latest Flagship Pioneering-backed biotech to shed sta...
After some earlier data sparked questions from analysts, Avidity Biosciences has...
The Trump administration has canceled funding for an ongoing 30-year, nationwide...
Veterinary medicines European public assessment report (EPAR): Cimalgex, cimicox...
Veterinary medicines European public assessment report (EPAR): Cytopoint, lokive...
Veterinary medicines European public assessment report (EPAR): Leucofeligen FeLV...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...
Breaking: The WHO issued its starkest warning yet on the consequences of the abr...
Human medicines European public assessment report (EPAR): Steglatro, ertuglifloz...
The pharma will acquire Araris Biotech to gain access to a trio of preclinical A...
Human medicines European public assessment report (EPAR): Skilarence, dimethyl f...